These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25740566)

  • 1. TCGA Releases Head and Neck Cancer Data.
    Cancer Discov; 2015 Apr; 5(4):340-1. PubMed ID: 25740566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a personalized treatment of head and neck cancer.
    Gross AM; Cohen EE
    Am Soc Clin Oncol Educ Book; 2015; ():28-32. PubMed ID: 25993138
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular-targeted therapies in head and neck cancer.
    Rao SD; Fury MG; Pfister DG
    Semin Radiat Oncol; 2012 Jul; 22(3):207-13. PubMed ID: 22687945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting personal: Head and neck cancer management in the era of genomic medicine.
    Birkeland AC; Uhlmann WR; Brenner JC; Shuman AG
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2250-8. PubMed ID: 25995036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational genomics and head and neck cancer: toward precision medicine.
    Razzouk S
    Clin Genet; 2014 Nov; 86(5):412-21. PubMed ID: 25143247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of experimental therapeutics for head and neck cancer.
    Lee J; Moon C
    Exp Biol Med (Maywood); 2011 Apr; 236(4):375-89. PubMed ID: 21427235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
    Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
    Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant epigenetic modifications in radiation-resistant head and neck cancers.
    Lin HY; Huang TH; Chan MW
    Methods Mol Biol; 2015; 1238():321-32. PubMed ID: 25421668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies.
    Pezzuto F; Buonaguro L; Caponigro F; Ionna F; Starita N; Annunziata C; Buonaguro FM; Tornesello ML
    Oncology; 2015; 89(3):125-36. PubMed ID: 25967534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular targeted approaches in head and neck cancer].
    Yokota T
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():428-33. PubMed ID: 23513878
    [No Abstract]   [Full Text] [Related]  

  • 12. [IV. Molecular targeting therapy for head and neck cancer].
    Fujii M
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):867-70. PubMed ID: 23971133
    [No Abstract]   [Full Text] [Related]  

  • 13. Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer.
    Heitmann J; Geeleher P; Zuo Z; Weichselbaum RR; Vokes EE; Fetscher S; Seiwert TY
    Oral Oncol; 2014 Sep; 50(9):825-31. PubMed ID: 25017803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [II. Molecular targeting therapy for head and neck cancer].
    Tahara M
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1055-60. PubMed ID: 22896873
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition.
    Burtness B; Bauman JE; Galloway T
    Lancet Oncol; 2013 Jul; 14(8):e302-9. PubMed ID: 23816296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in EGFR signal pathway in correlation with response to treatment of head and neck cancers.
    Neuwirthová J; Pavel S; Rottenberg J; Kostřica R; Zdeněk M; Hajdúch M; Drábek J; Srovnal J; Berkovcová J
    Gulf J Oncolog; 2011 Jul; (10):7-10. PubMed ID: 21724523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
    Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
    Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized treatment selection in patients with head and neck cancer: do molecular markers meet the challenge?
    Singh B; Pfister DG
    J Clin Oncol; 2008 Jul; 26(19):3114-6. PubMed ID: 18474877
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical applications of genomics in head and neck cancer.
    Chung CH; Levy S; Yarbrough WG
    Head Neck; 2006 Apr; 28(4):360-8. PubMed ID: 16284976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical update on cancer: molecular oncology of head and neck cancer.
    Suh Y; Amelio I; Guerrero Urbano T; Tavassoli M
    Cell Death Dis; 2014 Jan; 5(1):e1018. PubMed ID: 24457962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.